Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma - PubMed
- ️Thu Jan 01 2009
. 2009 Oct 1;27(28):4709-17.
doi: 10.1200/JCO.2008.18.9498. Epub 2009 Aug 31.
Affiliations
- PMID: 19720929
- DOI: 10.1200/JCO.2008.18.9498
Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma
Hanne Krogh Jensen et al. J Clin Oncol. 2009.
Abstract
Purpose: We have previously demonstrated a significant negative impact of intratumoral neutrophils in metastatic renal cell carcinoma. This study assessed intratumoral neutrophils in localized clear cell renal cell carcinoma (RCC).
Patients and methods: The study comprised 121 consecutive patients who had a nephrectomy for localized RCC. Biomarkers (intratumoral CD8+, CD57+ immune cells, CD66b+ neutrophils, and carbonic anhydrase IX [CA IX]) were assessed by immunohistochemistry, and the relationship with clinical and histopathologic features and patient outcome was evaluated.
Results: The intratumoral neutrophils ranged from zero to 289 cells/mm(2) tumor tissue. The presence of intratumoral neutrophils was statistically significantly associated with increasing tumor size, low hemoglobin, high creatinine, and CA IX < or = 85%. In multivariate analysis, the presence of intratumoral neutrophils (hazard ratio [HR], 3.0; 95% CI, 1.7 to 5.4; P < .0001), pT stage T3b/T4 (HR, 2.1; 95% CI, 1.2 to 3.6; P = .007), and low hemoglobin (HR, 1.8; 95% CI, 1.0 to 3.1; P = .03) were independent prognostic factors significantly associated with short recurrence-free survival. The presence of intratumoral neutrophils was also an independent prognostic factor for cancer-specific survival (HR, 3.5; 95% CI, 1.9 to 6.4; P < .0001) and overall survival (HR, 3.1; 95% CI, 1.9 to 5.0; P < .0001). Applying the prognostic value of intratumoral neutrophils to the Leibovich low-/intermediate-risk group (n = 78) showed a 5-year recurrence-free survival of 53% (95% CI, 34.6% to 71.8%; presence of intratumoral neutrophils) versus 87% (95% CI, 77.8% to 96.8%; absence of intratumoral neutrophils). The estimated concordance index was 0.74 using the Leibovich risk score and 0.80 when intratumoral neutrophils were added.
Conclusion: The presence of intratumoral neutrophils is a new, strong, independent prognostic factor for short recurrence-free, cancer-specific, and overall survival in localized clear cell RCC.
Similar articles
-
Impact of immune parameters on long-term survival in metastatic renal cell carcinoma.
Donskov F, von der Maase H. Donskov F, et al. J Clin Oncol. 2006 May 1;24(13):1997-2005. doi: 10.1200/JCO.2005.03.9594. J Clin Oncol. 2006. PMID: 16648500
-
Lam JS, Shvarts O, Said JW, Pantuck AJ, Seligson DB, Aldridge ME, Bui MH, Liu X, Horvath S, Figlin RA, Belldegrun AS. Lam JS, et al. Cancer. 2005 Jun 15;103(12):2517-25. doi: 10.1002/cncr.21127. Cancer. 2005. PMID: 15880379
-
Ilie M, Hofman V, Ortholan C, Bonnetaud C, Coëlle C, Mouroux J, Hofman P. Ilie M, et al. Cancer. 2012 Mar 15;118(6):1726-37. doi: 10.1002/cncr.26456. Epub 2011 Aug 25. Cancer. 2012. PMID: 21953630
-
Interleukin-2 based immunotherapy in patients with metastatic renal cell carcinoma.
Donskov F. Donskov F. Dan Med Bull. 2007 Nov;54(4):249-65. Dan Med Bull. 2007. PMID: 18208677 Review.
-
Biomarkers in clear cell renal cell carcinoma.
George S, Bukowski RM. George S, et al. Expert Rev Anticancer Ther. 2007 Dec;7(12):1737-47. doi: 10.1586/14737140.7.12.1737. Expert Rev Anticancer Ther. 2007. PMID: 18062748 Review.
Cited by
-
Polymorphonuclear Neutrophils and Tumors: Friend or Foe?
Szulc-Kielbik I, Klink M. Szulc-Kielbik I, et al. Exp Suppl. 2022;113:141-167. doi: 10.1007/978-3-030-91311-3_5. Exp Suppl. 2022. PMID: 35165863
-
Bioinformatics Analysis of Prognostic Value of SPC24 in ccRCC and Pan-Cancer.
Zhang J, Chen X, Wang J, Zhang P, Han X, Zhang Y, Wang Y, Yang X. Zhang J, et al. Int J Gen Med. 2022 Jan 23;15:817-836. doi: 10.2147/IJGM.S348859. eCollection 2022. Int J Gen Med. 2022. PMID: 35125884 Free PMC article.
-
Activated neutrophils exert myeloid-derived suppressor cell activity damaging T cells beyond repair.
Aarts CEM, Hiemstra IH, Béguin EP, Hoogendijk AJ, Bouchmal S, van Houdt M, Tool ATJ, Mul E, Jansen MH, Janssen H, van Alphen FPJ, de Boer JP, Zuur CL, Meijer AB, van den Berg TK, Kuijpers TW. Aarts CEM, et al. Blood Adv. 2019 Nov 26;3(22):3562-3574. doi: 10.1182/bloodadvances.2019031609. Blood Adv. 2019. PMID: 31738831 Free PMC article.
-
Kelsh RM, McKeown-Longo PJ. Kelsh RM, et al. Trends Cancer Res. 2013 Jan 1;9:1-13. Trends Cancer Res. 2013. PMID: 24634571 Free PMC article.
-
Effects of obesity on immune responses to renal tumors.
Chehval V, Norian LA. Chehval V, et al. Immunol Res. 2014 Aug;59(1-3):211-9. doi: 10.1007/s12026-014-8533-0. Immunol Res. 2014. PMID: 24838144 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous